SEC Form D · filed September 17, 2019
ZIOPHARM ONCOLOGY INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Jill M. Buck · Boston, MAExecEd Braswell · Brentwood, TNExec · DirectorBill Sasser · Brentwood, TNDirectorMurat Ozbaydar · New York, NYExecDawn Howe · Grand Cayman, Cayman IslandsDirectorAravt Global LLC · New York, NYDirectorSath M. Shukla · Boston, MAExecBradford G. Jackson · Seattle, WAExecStephen J. Ketchum · New York, NYDirectorHeidi M. Hagen · Boston, MADirectorEleanor M. De Groot · Boston, MAExecUmit Alptuna · New York, NYExecJames D. Mitchell · Seattle, WAExecArthur N. Budge, Jr · CAMARILLO, CAExec · DirectorAli Hamed · New York, NYDirectorYieldStreet Management LLC · New York, NYDirectorRob Heyvaert · NEW YORK, NYExecKristy R. Trieste · NEW YORK, NYDirectorMark R. Kessler · New York, NYExecJason K. Mendelson · Boulder, CODirectorSath M. Shukla · Boston, MAExecHeidi M. Hagen · Boston, MADirectorEleanor M. De Groot · Boston, MAExecJill M. Buck · Boston, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗